 Rezulin
Lawsuit News
September 8, 2003
Rezulin Lawsuits May Be Getting
Harder to Fight Off
Rezulin lawsuits are the result of new findings published
by the Mayo Clinic Proceedings. The findings show that
diabetes drugs may cause heart failure and cause fluid buildup in
some patients. The first drug in the newest class of diabetes drugs
was Rezulin. In March 2000 regulators found the drug to pose such
a great risk of adverse effects that a Rezulin recall was issued.
The new information about popular type-2 diabetes drugs may have
a high financial implication for Pfizer Inc., which owns Rezulin
after purchasing Warner-Lambert company and is currently battling
thousands of Rezulin lawsuits. Allegations against Rezulin maker
Warner-Lambert have been that the company failed to inform consumers
of Rezulin health risks. Contact
us for more information on Rezulin side effects.
April 22, 2003
Pfizer must defend Rezulin lawsuit
An appeal court reinstated a Rezulin lawsuit that was dismissed
in October 2001 in a lower court. The Rezulin lawsuit alleged that
Pfizer’s Warner-Lambert unit hid Rezulin safety risks and
continued to aggressively market Rezulin despite the serious liver
damages being reported. Rezulin class action lawsuit status is currently
being sought for the damages suffered by Rezulin patients.
Contact
us for more information on Rezulin side effects.
April 18, 2003
Hispanics informed of Rezulin lawsuit rights
A high number of diabetic patients that used Rezulin prior to the
March 2000 recall have been filing Rezulin lawsuits for the deadly
and serious effects Rezulin caused. A June 2002 L.A. Times article
was written stating legal documents exist showing that Warner Lambert
targeted Latinos while marketing Rezulin, as well as paying doctors
to have their diabetic patients switch to using Rezulin. Now, Hispanic
Rezulin patients are becoming better informed of how the judicial
system can help recover damages for the serious Rezulin side effects
suffered.
April 3, 2003
Manhattan jury rules against Rezulin company
A $2 million verdict favored a former Rezulin patient that suffered
Rezulin side effects, unanimously deciding there was “clear
and convincing” evidence showing Warner-Lambert misrepresented
or omitted Rezulin material information to physicians. At the time
of the Rezulin recall there had been around one hundred people that
either died or suffered from acute liver failure that required liver
transplant because of Rezulin diabetes drug. Pfizer (which acquired
Warner-Lambert in June 2000) is appealing the Rezulin decision.
The world’s largest drug maker, Pfizer has had thousands of
Rezulin lawsuits filed against the company.
March 31, 2003
Rezulin class action lawsuit denied
In September 2002, U.S. judge denied a nationwide Rezulin class
action lawsuit and now a California appeals court denied a Rezulin
class action lawsuit for California residents as well. Although
this may appear a small victory for Pfizer, the world’s largest
drug company has had thousands of Rezulin lawsuits filed against
them, paying $11.5 million, $23.6 million, and $2 million for Rezulin
lawsuits the company lost, in addition to paying $43 million to
settle.
February 8, 2001
General Accounting Office finds Rezulin fatalities
more common amongst women patients.
The GAO found that eight out of ten of the prescription drugs FDA
recalled since January 1, 1997 may have greater health risks amongst
women than men. Two thirds of the Rezulin deaths due to
liver failure were women, but this may be attributed to the
fact that Rezulin was prescribed to more women than men. CONTACT
US for Rezulin lawsuit information if you or a loved one are
suffering from Rezulin side effects.
October 16, 2000
New medication for type-2 diabetes reported by
the MayoClinic.
Rezulin was pulled from the market in March 2000 due to the Rezulin
liver
failures resulting in death that was occurring. Since then rosiglitazone
and pioglitazone that offer the same benefits as Rezulin without
the same risk. Rezulin is linked to at least 60 deaths. CONTACT
US for Rezulin lawsuit information if you or a loved one are
suffering from Rezulin side effects.
March 22, 2000
Diabetes drug Rezulin recalled.
Rezulin is linked to at least 63 liver
poisoning deaths and has been used by at least 750,000 Americans
when the FDA
ordered the Rezulin recall. The FDA is urging all Rezulin patients
to see their doctors before completely discontinuing the use of
the drug. Two new drugs Avandia and Actos are said to offer the
same benefits as Rezulin without the dangerous Rezulin side
effects. The manufacturer of Rezulin, Warner-Lambert removed
the diabetes drug after the FDA requested it but continued to say
they are confident in the safety of their drug. Currently, there
have been numerous Rezulin lawsuit settlements because of the liver
failure deaths associated to the drug. CONTACT
US for Rezulin lawsuit information if you or a loved one are
suffering from Rezulin side effects.
March 22, 2000
FDA questioned about approving diabetes drug Rezulin
knowing the toxic side effects from the start.
The FDA
finally convinced Warner-Lambert to pull Rezulin from the U.S.
market after the 63 Rezulin liver failures resulted in death and
90 cases of liver
failure. The FDA is under scrutiny because people are wondering
why the FDA approved Rezulin with speed when they knew about the
toxic side effects the diabetes drug can lead to. CONTACT
US for Rezulin lawsuit information if you or a loved one are
suffering from Rezulin side effects.
June 17, 1999
Stricter controls on diabetes drug Rezulin is FDA
placed.
The FDA
placed stricter controls on the diabetes drug Rezulin saying doctors
should use the drug as only a last resort for patients who do not
respond to other therapies. The FDA also noted that Rezulin should
not be used alone but along with other diabetes
drugs like insulin. In March 1999, the advisory committee investigated
the link between Rezulin and 40 cases of liver failure, including
28 deaths and until now has been considering the stricter controls.
The FDA indicated that Warner-Lambert must send letters to doctors
informing them of the new requirements regarding Rezulin. CONTACT
US for Rezulin lawsuit information if you or a loved one are
suffering from Rezulin side effects.
top - Rezulin Lawsuit News
March 26, 1999
The FDA advisory committee recommended the continued
use of Rezulin despite the controversial diabetes drug that has
been linked to 28 deaths.
The panel ruled Rezulin would stay on the market but with limitations
that include:
- Rezulin should be used only with other diabetes drugs, like
insulin, unless there is no other therapy that works for the patient.
- New labeling must be included, as well as new patient education
program designed to emphasize the risks of Rezulin liver damage
and/or death.
- Frequent monitoring of the liver in Rezulin patients.
The director of Public Citizen, Sidney Wolfe said that, “every
additional month on the market for Rezulin means longer duration
of therapy for hundreds of thousands of patients with concomitant
increased risk
of liver damage and possible death or the need for transplantation
because of liver failure.” Rezulin has already been taken off
the market in Britain in December 1997. The FDA
committee is under scrutiny because some of the scientific advisers
that conducted research were financed in some way by the manufacturer
of Rezulin. CONTACT
US for Rezulin lawsuit information if you or a loved one are
suffering from Rezulin side effects.
March 26, 1999
FDA panel reviews Rezulin.
Rezulin diabetes drug has been
under FDA review due to the risks associated to Rezulin. The popular
diabetes drug has been linked to 28 deaths so far. Rezulin is taken
by 750,000 Americans that suffer from type-2
diabetes.
March 25, 1999
The FDA panel reviews Rezulin diabetes drug linked
to numerous deaths.
The FDA advisory committee will meet to review the safety issue
of diabetes drug Rezulin that was seen as a wonder drug. Now linked
to 28 deaths a health researcher at George Washington University
thinks, “this drug simply does not show benefits to outweigh
its risks. As we focus on those risks, it tells us that this drug
does not belong on the market today.” Rezulin has been used
by more than 1.5 million people and has been one of Warner-Lambert’s
best selling drugs. In 1998 they had $750 million in sales from
Rezulin alone. CONTACT
US for Rezulin lawsuit information if you or a loved one are
suffering from Rezulin side effects.
December 2, 1998
New diabetes drug Rezulin is linked to 33 deaths.
CNN confirmed the Los Angeles Times Sunday report on Rezulin’s
link to 33 deaths. An FDA
official said that Rezulin is a highly toxic and potentially fatal
drug that must be closely monitored. Rezulin, manufactured by Warner-Lambert
was FDA approved on the “fast track” approval process
in January 1997, allowing Rezulin to be approved in just six months
opposed to the years it normally takes. The FDA felt the “fast
track” approval process was warranted because of the seriousness
of the diabetes disease. Other FDA officials that were involved
in the Rezulin review process noted the serious Rezulin side
effects, including nausea, fatigue, jaundice, and irreversible
liver failure. Recommendations to doctors were sent by the FDA to
test Rezulin patients for liver damage every month for the first
eight months and then every two months after the first year. While
the FDA said they stick to these recommendations, later on the FDA
ended up changing the Rezulin label four times, increasing the restrictions
on liver damage testing each time up until the Rezulin recall in
March 2000. CONTACT
US for Rezulin lawsuit information if you or a loved one are
suffering from Rezulin side effects.
top - Rezulin Lawsuit News
|
